Association members and partners

"LUPIN"

"LUPIN" is a transnational pharmaceutical company, one of the major manufacturers of high-grade medicinal means of global standard.

The "LUPIN" company was founded in 1967. Its headquarters is located in Mumbai, India. The company has opened its representative offices in England, the United States, Japan, Thailand, China, Russia and other countries. Its production facilities include ten high-tech plants in India and one in Japan. The company employs more than 9 thousand highly qualified workers.

20 brand names of the "LUPIN" company hold an honoured 3rd place in India in the corresponding sectors of the pharmaceutical market.
"LUPIN" is a dynamically developing company with an annual turnover of more than 700 million dollars.

The range of the products manufactured includes anti-bacterial, cardiovascular, anti-allergic, anti-diabetic, neurotropic, antiphlogistic and anaesthetic means, phytopreparations and other goods.
"LUPIN" is one of the most significant world manufacturers of anti-tuberculosis medicines. Thus, the company produces 70 % of all world ethambutol demand, and 30 % of overall rifampicin demand. The company holds a European patent for the combined anti-tuberculosis kit it produces, and is on the official list of manufacturers of anti-tuberculosis means, approved by the World Organisation of Healthcare.

"LUPIN" is the major manufacturer of cephalosporin. The company has received a permit from the FDA (The Department of food product and medicinal means quality control in the US) to sell cefuroxime axetil in the United States. The production of injectional cephalosporin is approved by the UK MCA (Great Britain). The company is a pioneer in the field of creating a special pelleted form of cephalosporin (cefalexin и cefadroxil), which allows the patients to take the drug only once every 24 hours.

The "LUPIN" company has arranged the wide-scale production of statin.
"LUPIN" manufactures a wide range of safe and high quality drugs of herbal origin, the effectiveness of which has been proved in clinic conditions .
The "LUPIN" company has set forth 145 patent applications. The company is the owner of 53 patents.

The "LUPIN" company has registered more than 100 medicinal means in more than 70 countries throughout the world.
The "LUPIN" company started operating in Russia in 1993. 25 medicinal means, including antibacterial, antiviral, cardiologic, nonsteroidal anti-inflammatory agents have been registered. The company is the supplier of the complete range of modern anti-tuberculosis medical means, including substances (essences).

Having achieved significant success, the "LUPIN" company has decided to broaden its business part in the Russian pharmaceutical market and put forth for registration a variety of drugs, including medical means of herbal origin that are noted for their high-grade effectiveness, excellent tolerance and complete safety.
One of the prospective directions of the company activity on the Russian market and worldwide is development and production of modern natural origin medicinal means that are standardized and have proved effective and safe. The products are based on the thousand-year-old practice of Ayurveda medicine.

The "LUPIN" company devotes much attention to the promotion of the goods manufactured, using all marketing instruments, well-prepared and motivated personnel, developed infrastructure and distinguished coordination between the manufacturer, distributors and drug stores. It is always aimed at satisfying the needs and the constantly growing demand of different social layers in Russia in high-quality and effective medicinal means.

The "LUPIN" company is open for mutually beneficent and long-term collaboration with reliable partners.